Global Depression Treatment Therapy Market Report 2022-2028: Selective Serotonin Reuptake Inhibitors (SSRIs) Hold Significant Share
October 10, 2022 06:43 ET
|
Research and Markets
Dublin, Oct. 10, 2022 (GLOBE NEWSWIRE) -- The "Global Depression Treatment Therapy Market Research and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering. The global...
Nexstim NBS 5+ System Continues to Generate Interest in the US
October 06, 2022 05:00 ET
|
Nexstim Oyj
Press release, Helsinki, 6 October 2022 at 12 PM (EEST) Nexstim NBS 5+ System Continues to Generate Interest in the US Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that Drs....
Pacific Solstice Offers Mental Health Program That Quickens Progress in Junior High and High School Students
September 09, 2022 09:00 ET
|
Pacific Solstice
MISSION VIEJO, Calif., Sept. 09, 2022 (GLOBE NEWSWIRE) -- "Recent national surveys of young people have shown alarming increases in the prevalence of certain mental health challenges— in 2019, one...
Nexstim Receives an NBS 5+ System Order from Seattle Children’s Hospital
June 02, 2022 03:00 ET
|
Nexstim Oyj
Press release, Helsinki, 2 June 2022 at 10 AM (EEST) Nexstim Receives an NBS 5+ System Order from Seattle Children’s Hospital Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") today...
Nexstim Receives an NBS 5+ System Order from a US Customer
April 06, 2022 02:00 ET
|
Nexstim Oyj
Press release, Helsinki, 6 April 2022 at 9 AM (EEST) Nexstim Receives an NBS 5+ System Order from a US Customer Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces having received...
Nexstim Receives a System Upgrade Order from a Customer in Finland
February 16, 2022 02:30 ET
|
Nexstim Oyj
Press release, Helsinki, 16 February 2022 at 9:30 AM (EET) Nexstim Receives a System Upgrade Order from a Customer in Finland Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") has received...
Nexstim Abp licensierar ut teknik till det amerikanska medicinteknikföretaget Magnus Medical, Inc. för behandling av neuropsykiatriska tillstånd
February 14, 2022 02:00 ET
|
Nexstim Oyj
Företagsmeddelande, insiderinformation, Helsingfors 14.2.2022 kl. 9.00 (EET) Nexstim Abp licensierar ut teknik till det amerikanska medicinteknikföretaget Magnus Medical, Inc. för behandling av...
Nexstim Oyj lisensoi kehittämäänsä teknologiaa yhdysvaltalaiselle lääkintäteknologiayhtiö Magnus Medical, Inc.:ille käytettäväksi neuropsykiatrisien häiriöiden hoitoon
February 14, 2022 02:00 ET
|
Nexstim Oyj
Yhtiötiedote, sisäpiiritieto, Helsinki, 14.2.2022 klo 9.00 (EET) Nexstim Oyj lisensoi kehittämäänsä teknologiaa yhdysvaltalaiselle lääkintäteknologiayhtiö Magnus Medical, Inc.:ille käytettäväksi...
Nexstim Plc to license technology to US-based medical technology company Magnus Medical, Inc. for the treatment of neuropsychiatric disorders
February 14, 2022 02:00 ET
|
Nexstim Oyj
Company Announcement, Inside Information, Helsinki, 14 February 2022, at 9 AM (EET) Nexstim Plc to license technology to US-based medical technology company Magnus Medical, Inc. for the treatment of...
Nexstim Receives an NBS 5+ System Order from a Customer in the US
January 24, 2022 02:00 ET
|
Nexstim Oyj
Press release, Helsinki, 24 January 2022 at 9 AM (EET) Nexstim Receives an NBS 5+ System Order from a Customer in the US Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces having...